Fairvalue-Calculator Fairvalue-Calculator
EN DE

BSF Enterprise Plc, (BSFAF) Fair Value & Analysis

Healthcare · US · Market cap $3.1M

Price$0.0160
Fair Value$0.0800
Upside+400.0%
Quality95/100
Evidence: Low Range $0.0600 – $0.1000

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

BSF Enterprise Plc, (BSFAF) currently trades at $0.0160, while our model-based Fair Value estimate is $0.0800 — implying the stock looks roughly 400.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing, and e-commerce sectors. It also engages in biotechnology start-up; lab-grown cornea and meat research; and development of skin technology. The company was incorporated in 2018 and is based in London, the United Kingdom.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is BSF Enterprise Plc, (BSFAF) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.0800 versus a price of $0.0160 — about +400% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BSFAF?
Our 21-model fair value for BSF Enterprise Plc, is $0.0800 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.0160.
What is the quality score of BSFAF?
BSF Enterprise Plc, has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.